Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571161
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's DiseaseEli Lilly and CompanyNot Yet RecruitingPhase 3
NCT07571161Not Yet Recruiting
Phase 3
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired...Eli Lilly and Company
NCT07569315
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-respondersBedaya HospitalNot Yet RecruitingPhase 2
NCT07569315Not Yet Recruiting
Phase 2
Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger O...Bedaya Hospital
NCT07569692
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography)-2CardioVascular Research Foundation, KoreaNot Yet RecruitingNot Applicable
NCT07569692Not Yet Recruiting
Not Applicable
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulne...CardioVascular Research F...
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07569393
Mama Empoderada: Parenting and Mental Health InterventionUniversity of MichiganNot Yet RecruitingNot Applicable
NCT07569393Not Yet Recruiting
Not Applicable
Mama Empoderada: Parenting and Mental Health InterventionUniversity of Michigan
NCT07569913
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid TestbioLytical LaboratoriesNot Yet RecruitingNot Applicable
NCT07569913Not Yet Recruiting
Not Applicable
A Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis...bioLytical Laboratories
NCT07570342
Comparison of Two Types of Calcium (Ca²⁺) Ionophore Treatments for Oocyte Activation in Cases of Suboptimal Fertilization PotentialART Fertility Clinics LLCNot Yet RecruitingNot Applicable
NCT07570342Not Yet Recruiting
Not Applicable
Comparison of Two Types of Calcium (Ca²⁺) Ionophore Treatments for Oocyte Activa...ART Fertility Clinics LLC
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07570511
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy, FranceNot Yet RecruitingNot Applicable
NCT07570511Not Yet Recruiting
Not Applicable
Point of Care Testing INR in Antiphospholipid SyndromeCentral Hospital, Nancy,...
NCT07570537
TubeClear System Evaluation in Pediatric PatientsChildren's Mercy Hospital Kansas CityNot Yet RecruitingNot Applicable
NCT07570537Not Yet Recruiting
Not Applicable
TubeClear System Evaluation in Pediatric PatientsChildren's Mercy Hospital...
NCT07571330
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de Nuevo LeonRecruitingNot Applicable
NCT07571330Recruiting
Not Applicable
Upper Punctal Plug Occlusion in Previous Lower Punctal Occlusion.Universidad Autonoma de N...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07568730
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study to Evaluate the Safety and Efficacy of Lacripep 4 μM Ophthalmic Solution in Subjects With Neurotrophic KeratitisTearSolutions, Inc.RecruitingPhase 2
NCT07568730Recruiting
Phase 2
A Multicenter, Randomized, Vehicle-Controlled, Double-Masked to Open-Label Study...TearSolutions, Inc.
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07568782
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.Lille UniversityNot Yet Recruiting
NCT07568782Not Yet Recruiting
—
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Im...Lille University
NCT07568600
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hyaluronate Carbomer Composite HydrogelThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07568600Not Yet Recruiting
Not Applicable
Development and Clinical Study of Burn Wound Nursing Dressing Based on Sodium Hy...The First Affiliated Hosp...
NCT07570667
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research PlatformsCenter for Molecular Fingerprinting Research Nonprofit LLCNot Yet Recruiting
NCT07570667Not Yet Recruiting
—
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promo...Center for Molecular Fing...
NCT07568834
Impact of Pelvic Pain PodcastVanderbilt University Medical CenterRecruitingNot Applicable
Result Breakdown
Not yet recruiting14 (70%)
Recruiting5 (25%)
Enrolling by invitation1 (5%)
not_applicable11 (55%)
Phase 24 (20%)
Not Specified4 (20%)
Phase 31 (5%)